What happens inside lentivirus or influenza virus infected cells: insights into regulation of cellular and viral protein synthesis.
Efficient manipulation of the regulatory mechanisms controlling host cell gene expression provides the means for productive infection by animal viruses. Upon infecting the host cell, viruses must: (i) bypass the cellular antiviral defense mechanisms to prevent the translational blocks imposed by the interferon pathway; and (ii) effectively "hijack" the host protein synthetic machinery into mass production of virion protein components. The multicomponent regulatory nature of cellular gene expression has provided the means of selecting for a diverse range of mechanisms utilized by animal viruses to ensure that replication efficiency is maintained throughout the virus life cycle. One important research component of the careful examination of gene regulation is those studies that focus on elucidating the mechanisms by which viruses control mRNA translation during host cell infection. Much of the work in our laboratory has focused on elucidating the strategies by which human immunodeficiency virus type 1 and influenza virus regulate protein synthesis during infection. Here we describe the ways in which these two distinctly different RNA viruses ensure the selective and efficient translation of their viral mRNAs in infected cells. These strategies include circumvention of the deleterious effects associated with activation of the interferon-induced protein kinase, PKR. Herein we describe our methodologies designed to elucidate the translational regulation in cells infected by these viruses. We conclude with a brief summary of new directions, utilizing these methods, taken toward understanding the translational control mechanisms imposed by these viral systems, and how our studies of virally infected cells have allowed us to identify growth-regulating components of normal, uninfected cells.
Gale
M
M
Department of Microbiology, University of Washington School of Medicine, Seattle 98195, USA.
Katze
M G
MG
D002455:Cell Division / Q000502:physiology; D002460:Cell Line; D019084:Fluorescent Antibody Technique, Indirect; D015967:Gene Expression Regulation, Viral / Q000502:physiology*; D015497:HIV-1 / Q000502:physiology*; D050956:HSP40 Heat-Shock Proteins; D006801:Humans; D009975:Orthomyxoviridae / Q000502:physiology*; D011485:Protein Binding; D014176:Protein Biosynthesis; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism / Q000502:physiology; D011506:Proteins / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D012367:RNA, Viral / Q000235:genetics; D012097:Repressor Proteins / Q000378:metabolism; D014764:Viral Proteins / Q000096:biosynthesis* / Q000235:genetics; D019892:eIF-2 Kinase
C494651:DNAJC3 protein, human; D050956:HSP40 Heat-Shock Proteins; D011506:Proteins; D012333:RNA, Messenger; D012367:RNA, Viral; D012097:Repressor Proteins; D014764:Viral Proteins; D017346:Protein Serine-Threonine Kinases; D019892:eIF-2 Kinase